Immediate Impact
26 standout
Citing Papers
Advances in nanoparticles in targeted drug delivery–A review
2025 Standout
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
Works of Mike Rigby being referenced
Discovery of BT8009: A Nectin-4 Targeting Bicycle Toxin Conjugate for the Treatment of Cancer
2022
Abstract 4479: BT8009: A bicyclic peptide toxin conjugate targeting Nectin-4 (PVRL4) displays efficacy in preclinical tumor models
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mike Rigby | 52 | 23 | 4 | 30 | 8 | 79 | |
| Paul A. Tibbits | 57 | 30 | 20 | 42 | 9 | 180 | |
| Suzannah J. Harnor | 115 | 8 | 7 | 47 | 12 | 172 | |
| Sarah E. Ackermann | 37 | 9 | 17 | 13 | 9 | 76 | |
| Tam Pham | 100 | 18 | 2 | 32 | 10 | 166 | |
| Verena Waller | 48 | 42 | 6 | 26 | 7 | 83 | |
| Ronan P. Hanley | 142 | 9 | 3 | 58 | 8 | 199 | |
| Julia Yin | 28 | 6 | 11 | 19 | 7 | 65 | |
| Elsie Nolte | 71 | 6 | 18 | 27 | 9 | 96 | |
| Lianshan Zhang | 121 | 24 | 3 | 40 | 9 | 168 | |
| S. Liu | 41 | 9 | 26 | 40 | 10 | 93 |
All Works
Loading papers...